HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karen Schweikart Selected Research

21- (2- N,N- diethylaminoethyl)oxy- 7- methyl- 19- norpregna- 1,3,5(10)- triene- 3- O- sulfamate

6/2011Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karen Schweikart Research Topics

Disease

1Breast Neoplasms (Breast Cancer)
06/2011
1Carcinoma (Carcinomatosis)
06/2009
1Body Weight (Weight, Body)
01/2008

Drug/Important Bio-Agent (IBA)

121- (2- N,N- diethylaminoethyl)oxy- 7- methyl- 19- norpregna- 1,3,5(10)- triene- 3- O- sulfamateIBA
06/2011
1somatostatin receptor 2IBA
06/2009

Therapy/Procedure

1Therapeutics
06/2011
1Oral Administration
01/2008